You are here

  • Home
  • Archive
  • Volume 11, Issue 7
  • Correction: Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

https://doi.org/10.1136/jitc-2023-006699corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Lee L, Lim WC, Galas-Filipowicz D, et al. Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy. J ImmunoTher Cancer 2023; 11: e006699. doi: 10.1136/jitc-2023-006699

    This article has been corrected since it was first published. Author name Kwee Yong has been corrected.